ARCH Venture Fund XIII, L.P.

Insider Reports History

Location
Chicago, IL
Signature
ARCH Venture Partners XIII, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ARCH Venture Fund XIII, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. 10%+ Owner Common Stock 1,426,528 $36,533,382 $25.61 06 Mar 2026 Indirect

Insider Reports Filed by ARCH Venture Fund XIII, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYEL Lyell Immunopharma, Inc. 06 Mar 2026 1 +$12,499,985 4 10%+ Owner 09 Mar 2026, 16:34
LYEL Lyell Immunopharma, Inc. 25 Jul 2025 0 $0 3 10%+ Owner 29 Jul 2025, 21:23